Crowdonomics
All companies
BROBE logo

BROBE

Operating

Brobe International, Inc.

Retail & Consumer · Product · Austin, TX · Founded 2011

Functional and fashionable adaptive clothing for men, women, and children, recovering from major surgeries

Post-money valuation ⓘ
$7.7M
As of Jun 2023 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$471,440
Crowd $114K · Private $358K · 2 rounds since 2020
Latest share price
$1.15
Reg CF · Common Stock · Feb 2023 offering price

Financials

FY2020–FY2023 · from SEC filings · hover any figure for its source
$440K
$40K
2020
$468K
−$43K
2021
$388K
−$77K
2022
$258K
−$89K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed*
FY2021 reviewed
FY2022 reviewed
FY2023
Income statement
Revenue
$439,618
$468,383
$387,568
$257,710
Cost of goods sold
$170,707
$166,893
$109,049
$71,448
Gross margin
61%
64%
72%
72%
Net income
$39,599
-$43,191
-$76,920
-$88,604
Taxes paid
$0
$16,554
$9,858
$11,922
Balance sheet
Cash
$58,802
$31,913
$25,186
$28,125
Accounts receivable
$2,858
$123,265
$1,014
$1,014
Total assets
$475,268
$432,333
$473,525
$488,277
Short-term debt
$44,107
$118,319
$195,013
$173,426
Long-term debt
$577,290
$466,893
$471,994
$504,407
Total liabilities
$621,397
$585,212
$667,007
$677,833
Other
Headcount
—
5
5
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$7.6M
pre-money
Reg CF · Common · Feb 2023

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Principal holders% as the filing states it, Feb 15, 2023

  • Owned Cynthia Allison Jenkins-5,750,000 Common Stock86.9%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $113.9K / $1.2MInvestors 202Post-money $7.7M

Team

10 people
Allison SchickelFounder
Founder and CEO

Allison is a wife, mother of three, CEO, mentor, and speaker. Allison was inspired to create the original "Brobe" – a patented bra and robe combination for women undergoing breast surgeries – when a friend diagnosed with breast cancer described the pain, discomfort, and difficulty of healing while managing pain, swelling, and post-op drains for weeks. Realizing the lack of functional and feminine products available for women, she created something that gave women dignity and beauty during (what most would say is) the most challenging time of their life. Brobe has become the leader in adaptive clothing by expanding beyond the breast cancer market to offer a range of products globally for cosmetic surgeries, open heart, organ transplants, and pediatric surgery recovery. Allison has won numerous awards, including ABJ’S Profiles in Power, Dallas Market Center’s Next Big Thing, and Women’s Chamber Rising Star, and was honored as one of ten businesswomen selected for the 2017 Tory Burch Fellows program. She’s an honorary graduate from the School of Hard Knocks and has mentored students at McCombs School of Business, UT’s School of Communications, and St Edwards University Entrepreneurship program.

Cynthia Allison Jenkins Schickel
CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer
Susan Crenshaw
Director of B2B Sales and Marketing

Susan is an accomplished B2B, B2C, and Direct Response veteran. Working both in front of and behind the camera for more than 3 decades she has developed deep ties in the product marketing industry helping to create and execute a multitude of successful campaigns, and more than $500 million in sales. She is thrilled to be directing Brobe International’s first foray into B2B with the goal of making Brobe’sfull line of products available to everyone needing support and care during and after their recovery from surgery. “Brobe International’s B2B division is truly an honor to be developing. The product is impeccable but its mission is even more important to me. More than 50 million surgeries are performed annually in the US alone, a staggering number of patients and families to touch. I am both proud and incredibly grateful to be part of making that possible. Incidentally, I am also a long-time Brobe customer and a huge fan.”-Susan

Denise Pierosh
Bookkeeper / Accounting

Denise has 20 years of accounting experience and has been working with Brobe for five years. She handles all the accounting, bookkeeping, invoicing, reports, and monthly books. Denise has extensive experience working with D2C and B2B companies, from small businesses to large corporations.

Gilbert Yang
Manufacture Broker

Gilbert has 30+ years as a manufacturing broker and supply chain specialist and information management.Gilbert has worked with Brobe for 8 years being the go to for all supply chain, distribution and import/export expertise between China and the US.

Jeff Meltzer
Senior Advisor over B2B Sales and Marketing

Jeff Meltzer is an award-winning and acknowledged leader in the B2B and DTC Industries. His more than 35 years of experience in the industry have generated over $1.5 billion dollars in product sales to date. Jeff’s expertise includes the creation of hundreds of financial proformas, offer models, marketing campaigns, and thousands of retail store placements. He is recognized as one of the original creators of both the long form and short form infomercial formats, and has over 2000 shows, commercials, product videos, and social media campaigns, to his credit. Jeff has consulted on and produced campaigns for Blue Cross Blue Shield, Michelin, Dupont, Capital One, Aerus /Electrolux, Sharp, SeroVital, Worx, Furi, and ArmorAll, as well as numerous other classic campaigns. Jeff has been instrumental in envisioning and building the structure for Bobe’s introduction to B2B sales and marketing and will continue to be an invaluable advisor over the next years of company growth.

Jeff Wallace
Investment Advisor

Jeff resides in the Bay Area and works with global startup ecosystems and entrepreneurs. He’s an Adjunct Instructor for Entrepreneurship & Innovation at UC Berkeley and co-founder of Silicon Valley in Your Pocket, a global virtual startup accelerator serving 100s of companies across 30+ countries. He is an angel investor with equity positions in 180+ companies and an advisor & investor at Berkeley SkyDeck. He is an Executive Board Member for the Rutgers Business School Road to Silicon Valley Program. He worked at Cognizant & Brillio as GlobalHead for Mobility & UX practices. He is a keynote speaker at global tech & startup events. He holds a BA in Economics / Finance from Rutgers College and an MBA from UC Berkeley.

Holly Deleon
Advisor

Holly is the founder of Education Industry Representatives Group, a K-12 consulting company. Holly has 40+ years of building companies and taking their product from B-C and B-E. Holly has the vision for taking companies, with exceptional products, into the K-12 space using experienced sales reps to facilitate the relationships. Holly has spent her career advocating for the dignity of all children. She feels the work of Brobe is accomplishing the same dignity for women, children, and men undergoing traumatic stress after surgery.

Rachel Sanchez-Madhur
Advisor

Rachel has served as an advisor to Brobe International on marketing and product strategy since Jan 2020. Rachel is currently Vice President of Product at Nomi Health. Prior to Nomi Health, Rachel served as Executive Vice President of Product at One Drop for seven years. Before her career in healthcare startups, Rachel spent four years as an IP attorney representing clients in the life sciences sector. Rachel received a B.S.E. in Chemical Engineering from the University of Michigan and a J.D. from Harvard Law School.

Show 1 more person
Sandeep Madhur
Advisor

Sandeep has served as an advisor to Brobe International on financial strategy and operations since Jan 2020. Sandeep is currently a Sales Strategy consultant for hyper-growth software companies such as TripActions, Everlaw, Lattice, and Outreach. Previously, Sandeep covered Enterprise Software companies as an equity research analyst at J.P. Morgan and helped buildMuleSoft pre-IPO through its acquisition by Salesforce.com. Sandeep received a B.A. from the University of Rochester and an M.B.A. from the Yale School of Management.

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 4 annual reports (FY2022–FY2025)

202 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMay 31, 20240001665160-24-000945
    EDGAR
  • Form C-UJun 26, 20230001665160-23-001443
    EDGAR
  • Form C-ARApr 17, 20230001665160-23-000640
    EDGAR
  • Form C/AApr 17, 20230001665160-23-000635
    EDGAR
  • Form C/AFeb 21, 20230001665160-23-000280
    EDGAR
  • Form CFeb 15, 20230001665160-23-000254
    EDGAR
Source: ManualCIK 0001963961DEShare price $1.15

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.